BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 15774463)

  • 41. Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells.
    Liu Z; Van Rossen E; Timmermans JP; Geerts A; van Grunsven LA; Reynaert H
    J Hepatol; 2011 Jan; 54(1):132-41. PubMed ID: 20932596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Supervillin slows cell spreading by facilitating myosin II activation at the cell periphery.
    Takizawa N; Ikebe R; Ikebe M; Luna EJ
    J Cell Sci; 2007 Nov; 120(Pt 21):3792-803. PubMed ID: 17925381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of three full-length human nonmuscle myosin II paralogs.
    Billington N; Wang A; Mao J; Adelstein RS; Sellers JR
    J Biol Chem; 2013 Nov; 288(46):33398-410. PubMed ID: 24072716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidermal growth factor-mediated transient phosphorylation and membrane localization of myosin II-B are required for efficient chemotaxis.
    Ben-Ya'acov A; Ravid S
    J Biol Chem; 2003 Oct; 278(41):40032-40. PubMed ID: 12874274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts.
    Shao H; Wang JH; Pollak MR; Wells A
    PLoS One; 2010 Nov; 5(11):e13921. PubMed ID: 21085685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myosin II isoforms in smooth muscle: heterogeneity and function.
    Eddinger TJ; Meer DP
    Am J Physiol Cell Physiol; 2007 Aug; 293(2):C493-508. PubMed ID: 17475667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MYH9-siRNA and MYH9 mutant alleles: expression in cultured cell lines and their effects upon cell structure and function.
    Li Y; Friedmann DR; Mhatre AN; Lalwani AK
    Cell Motil Cytoskeleton; 2008 May; 65(5):393-405. PubMed ID: 18330899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dorsal root ganglion neurons react to semaphorin 3A application through a biphasic response that requires multiple myosin II isoforms.
    Brown JA; Wysolmerski RB; Bridgman PC
    Mol Biol Cell; 2009 Feb; 20(4):1167-79. PubMed ID: 19109430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mosaic loss of non-muscle myosin IIA and IIB is sufficient to induce mammary epithelial proliferation.
    Nguyen-Ngoc KV; Silvestri VL; Georgess D; Fairchild AN; Ewald AJ
    J Cell Sci; 2017 Oct; 130(19):3213-3221. PubMed ID: 28821574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeted disruption of N-RAP gene function by RNA interference: a role for N-RAP in myofibril organization.
    Dhume A; Lu S; Horowits R
    Cell Motil Cytoskeleton; 2006 Aug; 63(8):493-511. PubMed ID: 16767749
    [TBL] [Abstract][Full Text] [Related]  

  • 51. IRF-2 is involved in up-regulation of nonmuscle myosin heavy chain II-A gene expression during phorbol ester-induced promyelocytic HL-60 differentiation.
    Chung MC; Kawamoto S
    J Biol Chem; 2004 Dec; 279(53):56042-52. PubMed ID: 15496418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of non-muscle myosin heavy chain in rat heart after immunosuppressive treatment.
    Rezzani R; Pompili E; Agostini C; Buffoli B; Bonomini F; Nori S; Fumagalli L; Bianchi R
    Int Immunopharmacol; 2006 Jun; 6(6):962-7. PubMed ID: 16644482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myosin IIB isoform plays an essential role in the formation of two distinct types of macropinosomes.
    Jiang J; Kolpak AL; Bao ZZ
    Cytoskeleton (Hoboken); 2010 Jan; 67(1):32-42. PubMed ID: 19743471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of non-muscle myosin heavy chain genes during Xenopus embryogenesis.
    Bhatia-Dey N; Taira M; Conti MA; Nooruddin H; Adelstein RS
    Mech Dev; 1998 Nov; 78(1-2):33-6. PubMed ID: 9858676
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of Nonmuscle myosin II-A regulatory light chain resists Sendai virus fusion with host cells.
    Das P; Saha S; Chandra S; Das A; Dey SK; Das MR; Sen S; Sarkar DP; Jana SS
    Sci Rep; 2015 May; 5():10395. PubMed ID: 25993465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A proteomic study of myosin II motor proteins during tumor cell migration.
    Betapudi V; Gokulrangan G; Chance MR; Egelhoff TT
    J Mol Biol; 2011 Apr; 407(5):673-86. PubMed ID: 21316371
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Heterogeneous expression of nonmuscle myosin heavy chain-B in mesangial cells of patients with Gitelman's syndrome.
    Sakumura T; Umemoto S; Fujii Z; Fujii K; Kawata Y; Minami M; Matsuzaki M
    Clin Nephrol; 2001 Mar; 55(3):238-42. PubMed ID: 11316245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The tip of the coiled-coil rod determines the filament formation of smooth muscle and nonmuscle myosin.
    Ikebe M; Komatsu S; Woodhead JL; Mabuchi K; Ikebe R; Saito J; Craig R; Higashihara M
    J Biol Chem; 2001 Aug; 276(32):30293-300. PubMed ID: 11395487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Menin, a tumor suppressor, associates with nonmuscle myosin II-A heavy chain.
    Obungu VH; Lee Burns A; Agarwal SK; Chandrasekharapa SC; Adelstein RS; Marx SJ
    Oncogene; 2003 Sep; 22(41):6347-58. PubMed ID: 14508515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Asymmetric distribution of myosin IIB in migrating endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction.
    Kolega J
    Mol Biol Cell; 2003 Dec; 14(12):4745-57. PubMed ID: 12960430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.